Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma

• Main Authors: Joy M. Davis (Author), Tullia Rushton (Author), Felicity Nsiah (Author), Rebecca L. Stone (Author), Anna L. Beavis (Author), Stéphanie L. Gaillard (Author), Alice Dobi (Author), Amanda N. Fader (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dedifferentiated endometrial carcinoma is a rare, highly aggressive subtype of endometrial cancer associated with poor survival outcomes. Current guidelines recommend treatment of advanced-stage disease with surgical staging or cytoreduction and platinum/taxane-based chemotherapy. Despite these appr...